Key Sessions
Nathan Lewis, PhD
KEYNOTE: Engineering Out Metabolic Barriers in CHO Cells
University of California, San Diego
Nuno Fontes
Advances in process and manufacturing technology platforms for the industrialization of allogeneic cell therapy
Bayer U.S. LLC
Tiago Matos
Digital Transformation: Accelerating Process Development and Enhancing Control Strategies
Merck
Jacqualyn Schulman, Ph.D.
Engineering CHO Cells to improve a post-translational modification for a bispecific antibody production
Bristol-Myers Squibb